- About Us
- Nano-Social Network
- Nano Consulting
- My Account
MFIC Corporation ("MFIC" or the "Company")(OTCBB: MFIC) announced today that it recently received notification that Pfizer Inc. ("Pfizer") had liquidated its position, approximately 600,000 shares, or approximately 6%, of the outstanding common stock of MFIC.
The Pfizer shares were acquired by its predecessor in interest, G.D. Searle, Inc.
In response to a questionnaire circulated in connection with the preparation of MFIC's 2007 Proxy Statement Pfizer supplied records indicating that it sold the shares in the public market in varying size lots between December 2005 and February 2007.
About MFIC Corporation
MFIC Corporation, through its Microfluidics Division, provides patented and proprietary high performance Microfluidizer® materials processing equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid structures available, and has provided manufacturing systems for more than 15 years.
The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to MFIC equipment customers.
For more information, please click here
Irwin Gruverman, CEO & Chairman
Robert P. Bruno, President & COO
Jack M. Swig, Investor Relations
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
New nano approach could cut dose of leading HIV treatment in half February 24th, 2017
Particle Works creates range of high performance quantum dots February 23rd, 2017